arrow
X

Xiao-Dong Mo

Peking University
H指数:38
被引数:4,907

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation

EB病毒感染及移植后淋巴组织增生性病变在儿科半相合异基因造血干细胞移植中的发生率及危险因素

2026-08-250
PRE
Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen

异基因造血干细胞移植治疗40岁以上获得性重症再生障碍性贫血患者的结局:应用白消安、氟达拉滨、减剂量环磷酰胺和抗胸腺细胞球蛋白的预处理方案

2026-07-030
PRE
Conditioning dose adjustment in obese adult patients with severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: a propensity score-matched analysis

异基因造血干细胞移植中肥胖成人重型再生障碍性贫血患者预处理剂量调整:一项倾向性评分匹配分析

2026-05-200
PRE
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse

第二种替代供者半合子干细胞移植可提高移植后人类白细胞抗原丢失性复发并发的髓系恶性肿瘤患者的生存率。

2026-04-060
PRE
Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study

替代供者,特别是单倍体相合供者,对具有不良风险AML的老年患者是安全有效的:一项多中心TROPHY研究

2026-04-020
OAAI
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomes

异基因移植后再生障碍性贫血的慢性移植物抗宿主病:临床特征、危险因素和生存结局

2026-04-010
PRE
Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

所有道路都通往罗马吗?在新靶向药物时代,获得治疗反应并接受自体干细胞移植的复发/难治性弥漫大B细胞淋巴瘤患者的异质性。

2025-12-150
OA
Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation

随机对照试验:研究抗胸腺细胞球蛋白联合低剂量移植后环磷酰胺预防半相合移植中移植物抗宿主病的效果

2025-12-014
OA
Cerebrospinal fluid profile associated with the incidence and outcomes of patients with chronic graft-versus-host disease after haploidentical hematopoietic stem cell transplantation

与单倍型造血干细胞移植后慢性移植物抗宿主病患者发病率和结局相关的脑脊液特征

2025-12-010
PRE
Clinical Characteristics, Treatment Response and Outcomes of Bronchiolitis Obliterans Syndrome in Children with Hematologic Malignancies Undergoing Haploidentical Hematopoietic Cell Transplantation with G-CSF/ATG-Based Protocol: A Single-Center Study

支气管闭锁综合征的临床特征、治疗反应及结局:一项基于G-CSF/ATG方案的单中心研究,探讨接受单倍体造血细胞移植的血液系统恶性肿瘤患儿的病例

2025-10-020
PRE
Can one scoring system fit all? Comparative validation of CAR-HEMATOTOX, ALL-HEMATOTOX, and eIPM for predicting immune effector cell-associated hematotoxicity following CAR-T therapy in hematologic malignancies

一个评分系统能否适用于所有情况?CAR-HEMATOTOX、ALL-HEMATOTOX和eIPM在预测血液恶性肿瘤CAR-T治疗后免疫效应细胞相关血液毒性中的比较验证

2025-10-010
PRE
Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study

Xenopax用于治疗糖皮质激素难治性急性移植物抗宿主病:RELAX研究

2025-09-300
OAAI